Skip to content
lifestyle.cleanweb.co
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NewAmsterdam Pharma N.V.
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
July 29, 2026
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
July 24, 2026
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
June 3, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
May 28, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
May 11, 2026
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
May 8, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
May 2, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2026
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
April 30, 2026
1
2
Next Page
→